| 前收市價 | 14.60 |
| 開市 | 14.60 |
| 買盤 | 14.10 |
| 賣出價 | 21.80 |
| 拍板 | 300.00 |
| 到期日 | 2024-09-20 |
| 今日波幅 | 14.60 - 14.60 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 51 |
ZacksBio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
Insider MonkeyBio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
ZacksBio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates
Bio-Rad (BIO) delivered earnings and revenue surprises of 12.25% and 0.23%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
